169 related articles for article (PubMed ID: 24088304)
1. Dilated cardiomyopathy-associated FHOD3 variant impairs the ability to induce activation of transcription factor serum response factor.
Arimura T; Takeya R; Ishikawa T; Yamano T; Matsuo A; Tatsumi T; Nomura T; Sumimoto H; Kimura A
Circ J; 2013; 77(12):2990-6. PubMed ID: 24088304
[TBL] [Abstract][Full Text] [Related]
2. Mammalian formin fhod3 regulates actin assembly and sarcomere organization in striated muscles.
Taniguchi K; Takeya R; Suetsugu S; Kan-O M; Narusawa M; Shiose A; Tominaga R; Sumimoto H
J Biol Chem; 2009 Oct; 284(43):29873-81. PubMed ID: 19706596
[TBL] [Abstract][Full Text] [Related]
3. Dilated cardiomyopathy-associated BAG3 mutations impair Z-disc assembly and enhance sensitivity to apoptosis in cardiomyocytes.
Arimura T; Ishikawa T; Nunoda S; Kawai S; Kimura A
Hum Mutat; 2011 Dec; 32(12):1481-91. PubMed ID: 21898660
[TBL] [Abstract][Full Text] [Related]
4. The actin-organizing formin protein Fhod3 is required for postnatal development and functional maintenance of the adult heart in mice.
Ushijima T; Fujimoto N; Matsuyama S; Kan-O M; Kiyonari H; Shioi G; Kage Y; Yamasaki S; Takeya R; Sumimoto H
J Biol Chem; 2018 Jan; 293(1):148-162. PubMed ID: 29158260
[TBL] [Abstract][Full Text] [Related]
5. Alpha B-crystallin mutation in dilated cardiomyopathy.
Inagaki N; Hayashi T; Arimura T; Koga Y; Takahashi M; Shibata H; Teraoka K; Chikamori T; Yamashina A; Kimura A
Biochem Biophys Res Commun; 2006 Apr; 342(2):379-86. PubMed ID: 16483541
[TBL] [Abstract][Full Text] [Related]
6. Two distinct phosphorylation events govern the function of muscle FHOD3.
Iskratsch T; Reijntjes S; Dwyer J; Toselli P; Dégano IR; Dominguez I; Ehler E
Cell Mol Life Sci; 2013 Mar; 70(5):893-908. PubMed ID: 23052206
[TBL] [Abstract][Full Text] [Related]
7. Expression and subcellular localization of mammalian formin Fhod3 in the embryonic and adult heart.
Kan-o M; Takeya R; Taniguchi K; Tanoue Y; Tominaga R; Sumimoto H
PLoS One; 2012; 7(4):e34765. PubMed ID: 22509354
[TBL] [Abstract][Full Text] [Related]
8. The formin FHOD1 in cardiomyocytes.
Dwyer J; Pluess M; Iskratsch T; Dos Remedios CG; Ehler E
Anat Rec (Hoboken); 2014 Sep; 297(9):1560-70. PubMed ID: 25125170
[TBL] [Abstract][Full Text] [Related]
9. Impact of cardiac myosin light chain kinase gene mutation on development of dilated cardiomyopathy.
Hodatsu A; Fujino N; Uyama Y; Tsukamoto O; Imai-Okazaki A; Yamazaki S; Seguchi O; Konno T; Hayashi K; Kawashiri MA; Asano Y; Kitakaze M; Takashima S; Yamagishi M
ESC Heart Fail; 2019 Apr; 6(2):406-415. PubMed ID: 30690923
[TBL] [Abstract][Full Text] [Related]
10. Structural analysis of four and half LIM protein-2 in dilated cardiomyopathy.
Arimura T; Hayashi T; Matsumoto Y; Shibata H; Hiroi S; Nakamura T; Inagaki N; Hinohara K; Takahashi M; Manatsu SI; Sasaoka T; Izumi T; Bonne G; Schwartz K; Kimura A
Biochem Biophys Res Commun; 2007 May; 357(1):162-7. PubMed ID: 17416352
[TBL] [Abstract][Full Text] [Related]
11. Transgenic Expression of the Formin Protein Fhod3 Selectively in the Embryonic Heart: Role of Actin-Binding Activity of Fhod3 and Its Sarcomeric Localization during Myofibrillogenesis.
Fujimoto N; Kan-O M; Ushijima T; Kage Y; Tominaga R; Sumimoto H; Takeya R
PLoS One; 2016; 11(2):e0148472. PubMed ID: 26848968
[TBL] [Abstract][Full Text] [Related]
12. Formin follows function: a muscle-specific isoform of FHOD3 is regulated by CK2 phosphorylation and promotes myofibril maintenance.
Iskratsch T; Lange S; Dwyer J; Kho AL; dos Remedios C; Ehler E
J Cell Biol; 2010 Dec; 191(6):1159-72. PubMed ID: 21149568
[TBL] [Abstract][Full Text] [Related]
13. Pediatric Dilated Cardiomyopathy-Associated
Woon MT; Long PA; Reilly L; Evans JM; Keefe AM; Lea MR; Beglinger CJ; Balijepalli RC; Lee Y; Olson TM; Kamp TJ
J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29431102
[TBL] [Abstract][Full Text] [Related]
14. Crucial Role of ROCK2-Mediated Phosphorylation and Upregulation of FHOD3 in the Pathogenesis of Angiotensin II-Induced Cardiac Hypertrophy.
Zhou Q; Wei SS; Wang H; Wang Q; Li W; Li G; Hou JW; Chen XM; Chen J; Xu WP; Li YG; Wang YP
Hypertension; 2017 Jun; 69(6):1070-1083. PubMed ID: 28438902
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations.
Purevjav E; Arimura T; Augustin S; Huby AC; Takagi K; Nunoda S; Kearney DL; Taylor MD; Terasaki F; Bos JM; Ommen SR; Shibata H; Takahashi M; Itoh-Satoh M; McKenna WJ; Murphy RT; Labeit S; Yamanaka Y; Machida N; Park JE; Alexander PM; Weintraub RG; Kitaura Y; Ackerman MJ; Kimura A; Towbin JA
Hum Mol Genet; 2012 May; 21(9):2039-53. PubMed ID: 22286171
[TBL] [Abstract][Full Text] [Related]
16. Novel mutations in the sarcomeric protein myopalladin in patients with dilated cardiomyopathy.
Meyer T; Ruppert V; Ackermann S; Richter A; Perrot A; Sperling SR; Posch MG; Maisch B; Pankuweit S;
Eur J Hum Genet; 2013 Mar; 21(3):294-300. PubMed ID: 22892539
[TBL] [Abstract][Full Text] [Related]
17. Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic Cardiomyopathy.
Ochoa JP; Sabater-Molina M; García-Pinilla JM; Mogensen J; Restrepo-Córdoba A; Palomino-Doza J; Villacorta E; Martinez-Moreno M; Ramos-Maqueda J; Zorio E; Peña-Peña ML; García-Granja PE; Rodríguez-Palomares JF; Cárdenas-Reyes IJ; de la Torre-Carpente MM; Bautista-Pavés A; Akhtar MM; Cicerchia MN; Bilbao-Quesada R; Mogollón-Jimenez MV; Salazar-Mendiguchía J; Mesa Latorre JM; Arnaez B; Olavarri-Miguel I; Fuentes-Cañamero ME; Lamounier A; Pérez Ruiz JM; Climent-Payá V; Pérez-Sanchez I; Trujillo-Quintero JP; Lopes LR; Repáraz-Andrade A; Marín-Iglesias R; Rodriguez-Vilela A; Sandín-Fuentes M; Garrote JA; Cortel-Fuster A; Lopez-Garrido M; Fontalba-Romero A; Ripoll-Vera T; Llano-Rivas I; Fernandez-Fernandez X; Isidoro-García M; Garcia-Giustiniani D; Barriales-Villa R; Ortiz-Genga M; García-Pavía P; Elliott PM; Gimeno JR; Monserrat L
J Am Coll Cardiol; 2018 Nov; 72(20):2457-2467. PubMed ID: 30442288
[TBL] [Abstract][Full Text] [Related]
18. A novel alpha-tropomyosin mutation associates with dilated and non-compaction cardiomyopathy and diminishes actin binding.
van de Meerakker JB; Christiaans I; Barnett P; Lekanne Deprez RH; Ilgun A; Mook OR; Mannens MM; Lam J; Wilde AA; Moorman AF; Postma AV
Biochim Biophys Acta; 2013 Apr; 1833(4):833-9. PubMed ID: 23147248
[TBL] [Abstract][Full Text] [Related]
19. Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy.
Lakdawala NK; Dellefave L; Redwood CS; Sparks E; Cirino AL; Depalma S; Colan SD; Funke B; Zimmerman RS; Robinson P; Watkins H; Seidman CE; Seidman JG; McNally EM; Ho CY
J Am Coll Cardiol; 2010 Jan; 55(4):320-9. PubMed ID: 20117437
[TBL] [Abstract][Full Text] [Related]
20. A Novel Titin Truncation Variant Linked to Familial Dilated Cardiomyopathy Found in a Japanese Family and Its Functional Analysis in Genome-Edited Model Cells.
Hirayama-Yamada K; Inagaki N; Hayashi T; Kimura A
Int Heart J; 2021 Mar; 62(2):359-366. PubMed ID: 33678800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
